Skip to content

Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy

Opioid Sparing Effect of Erector Spinae Block in Patients Undergoing Total Abdominal Hysterectomy; A Randomized Control Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07178262
Enrollment
60
Registered
2025-09-17
Start date
2025-08-01
Completion date
2025-10-30
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spinae Block, Enhanced Recovery After Surgery (ERAS) Protocol, Opioid

Brief summary

Hystrectomy is a surgical procedure that involves removal of uterus from the body of patient using a lower abdominal incision. This is an extremely painful procedure which causes discomfort and greatly increases opioids consumption in the peri-operative period. This can be reduced by using nerve blocks such as Erector spinae plane block.

Detailed description

Total abdominal hystrectomy is associated with significant pain due to large abdominal incision and significant surgical dissection. This greatly increases the consumption of Opioid in the peri-operative period. High dose opioid consumption is associated with constipation, nausea, vomiting and respiratory depression. This significantly hampers post operative recovery. Fascial plane blocks such as Erector spinae block provides significant analgesia greatly reducing opioid consumption and there by reducing the associated side effects.

Interventions

Bilateral Erector Spinae Block at T10 level using 30ml of 0.25% Bupivacaine will be administered under Ultrasound guidance before surgical incision.

DRUGPlacebo

Bilateral Erector Spinae Block at T10 level using 30ml of Normal saline will be administered under Ultrasound guidance before surgical incision.

Sponsors

Kulsoom International Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* American Society of Anesthesiologists (ASA) class: I, II and III . * Elective Hysterectomy under General Anesthesia.

Exclusion criteria

* Lack of consent * Body mass index \>35 kg/m2 * Allergic to study medicine * Opioid abuse or misuse disorder * Chronic pain

Design outcomes

Primary

MeasureTime frame
Total Intra-operative Fentanyl consumptionFrom surgical incision till end of surgery

Secondary

MeasureTime frameDescription
Total amount of IV Tramadol consumed in post operative periodFirst 24 hours after surgery
Post operative pain scoreBaseline that is pain score upon arrival in post anesthesia care unit in the post operative period and then at 1hours ,2 hours ,4 hours,6 hours,12 hours and 24 hours in the post operative periodThis will be assessed Visual Analog Scale

Countries

Pakistan

Contacts

Primary ContactWaqas Anjum, Principal Investigator, MBBS, FCPS
waqasanjum435@gmail.com+92-310-3308158
Backup ContactAbdul Rehman, MBBS,FCPS
rehman222@hotmail.com+92-333-5227329

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026